Clinical outcomes among patients with advanced non-small cell lung cancer who received targeted therapy in a real-world setting

被引：0
|
作者：
Yang, Mo
MacEwan, Joanna P.
Boppudi, Sai Sriteja
McClain, Monica
O'Hara, Richard
Liu, Frank
Paik, Paul K.
机构：
[1] EMD Serono, Rockland, MA USA
[2] Genesis Res, Hoboken, NJ USA
[3] Mem Sloan Kettering Canc Ctr, Thorac Oncol Serv, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9051
引用
收藏
页数：1
相关论文
共 50 条
  • [31] ctDNA assessment of EGFR mutation status in Chinese patients with advanced non-small cell lung cancer in real-world setting
    Zhang, Shirong
    Zhu, Lucheng
    Chen, Xueqin
    Zhang, Xiaochen
    Chen, Enguo
    Fang, Hongming
    Feng, Yuejuan
    Li, Yuping
    Wang, Xi
    Jiang, Zhongyu
    Wang, Yina
    Zhang, Zhihao
    He, Huijuan
    Ma, Shenglin
    JOURNAL OF THORACIC DISEASE, 2018, 10 (07) : 4169 - +
  • [32] Real-world clinical outcomes in patients with advanced ROS1+non-small cell lung cancer in the US
    Villacorta, Reginald
    Ray, Saurabh
    Yuan, Yong
    Vijapur, Sushupta
    Kim, Sonia
    Sun, Haiyan
    Myers, Sky
    Lam, Vincent
    CANCER RESEARCH, 2024, 84 (06)
  • [33] Completion of pembrolizumab in advanced non-small cell lung cancer: Real-world outcomes after two years of therapy (COPILOT)
    Fantoni, A.
    Warburton, L.
    Solomon, B.
    Alexander, M.
    Maddula, M.
    Da Silva, I. Pires
    Brown, L. J.
    Nagrial, A.
    Abu Al-Hial, F.
    Itchins, M.
    Pavlakis, N.
    Bowyer, S. E.
    ANNALS OF ONCOLOGY, 2023, 34 : S1682 - S1683
  • [34] Real-world outcomes of anti-EGFR therapy in advanced non-small cell lung cancer EGFR mutated in Peru
    Galvez-Nino, Marco
    Ruiz, Rossana
    Roque, Katia
    Coanqui, Ofelia
    Valdivieso, Natalia
    Olivera, Mivael
    Ganti, Apar Kishor
    Mas, Luis
    THORACIC CANCER, 2023, 14 (01) : 61 - 67
  • [35] Lung Cancer Prognostic Index Performance in US Real-World Advanced Non-Small Cell Lung Cancer Patients
    Shah, R.
    John, A.
    Alexander, M.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S391 - S391
  • [36] Treatment Patterns, Clinical Outcomes and Healthcare Costs of Advanced Non-Small Cell Lung Cancer: A Real-World Evaluation in Italy
    Franchi, Matteo
    Cortinovis, Diego
    Corrao, Giovanni
    CANCERS, 2021, 13 (15)
  • [37] Patient characteristics, treatment patterns, and clinical outcomes among patients with de novo advanced or metastatic (stage IIIB-IV) non-small cell lung cancer in a real-world setting
    Yang, Mo
    MacEwan, Joanna P.
    Boppudi, Sai Sriteja
    McClain, Monica
    O'Hara, Richard
    Paik, Paul K.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [38] Treatment patterns and real-world clinical outcomes of metastatic non-small cell lung cancer patients in the immunotherapy era
    Moser, S. Sharman
    Apter, L.
    Arunachalam, A.
    Gazit, S.
    Chodick, G.
    Siegelmann-Danieli, N.
    ANNALS OF ONCOLOGY, 2023, 34
  • [39] Clinical outcomes of nivolumab in patients with advanced non-small cell lung cancer in real-world practice, with an emphasis on hyper-progressive disease
    Kim, Soo Han
    Choi, Chang-Min
    Lee, Dae Ho
    Kim, Sang-We
    Yoon, Shinkyo
    Kim, Woo Sung
    Ji, Wonjun
    Lee, Jae Cheol
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (11) : 3025 - 3036
  • [40] Clinical outcomes of nivolumab in patients with advanced non-small cell lung cancer in real-world practice, with an emphasis on hyper-progressive disease
    Soo Han Kim
    Chang-Min Choi
    Dae Ho Lee
    Sang-We Kim
    Shinkyo Yoon
    Woo Sung Kim
    Wonjun Ji
    Jae Cheol Lee
    Journal of Cancer Research and Clinical Oncology, 2020, 146 : 3025 - 3036
12345